Krest
See it live →
The Reinvestment Compounder ROIC × growth
We took it to KrestTested
Eight years of Indian data · 2018 to 2026

The formula behind every great compounding story, high returns reinvested into growth, trailed the Indian market when run as a screen.

Ask any quality investor for the engine of wealth and you will hear the same equation: a high return on capital, multiplied by the runway to reinvest it. It is the arithmetic behind every famous compounder. We turned that exact arithmetic into a screen and ran it on eight years of Indian data. The single run trailed a plain index fund badly, and the deeper story, of when it worked, for whom, and why its own favourites fared worst, says more about paying for fame than about the formula being wrong.

We built 186 portfolios from the screen, one for every starting month, held one, three and five years. As with every strategy we test, the range of outcomes tells a fuller truth than the single line, and here the two disagree sharply.

Return by the month you happened to start
186 portfolios in all · held one year shown · top 30
Reinvestment CompounderNifty 500
Toggle the holding period. Under half the one year starts won; two thirds of the five year ones did.

Held one year, the compounders beat the index in about 46% of starts. Held three years, roughly 63%; held five, about 66%, at a median near 22% a year. Patience helped, as it usually does. But unlike the clear winners it never approached a sure thing, and the reason sits in the headline number below.

The shape of it: good years in the middle, famine at the start

Over a single year, half of all starts landed between roughly −21% and +91%, the best year above +142%, the worst near −36%. A generous spread. The trouble is where the lean years fell: heavily in the screen's opening stretch, which is exactly the stretch the single ten year line is forced to live through. Most windows that avoided that opening did respectably. The one everyone quotes did not.

The single run: the famous formula, famously behind

Straight through from 2018, the top thirty compounded at about 7.4% a year against the index's 12.5%, and ₹10 lakh grew to roughly ₹18 lakh while the index reached ₹26 lakh. Worse, the more faithfully you followed the ranking, the worse it got: the screen's ten favourite companies earned barely 1% a year through a 64% fall. The formula's arithmetic is not in question; what the market spent this period doing was repricing the famous compounders that arithmetic points to, and no screen built on fame survives its repricing.

₹10 lakh from 2018, the single path
Growth of the portfolio · vs Nifty 500
Top decileTop 30Nifty 500
The compounding screen, out compounded by the index it set out to beat.

The fall was ordinary; the recovery was not

Across start dates, the worst fall over a five year hold typically reached about 42% and topped out near 55%, no worse than the other small cap screens and gentler than several winners. Falling was not this screen's problem. Its problem was what came after: baskets priced for perfection recover slowly, because the repricing that hurt them is permanent, not cyclical. The clear winners fell as hard and climbed back faster.

Worst fall over five years, by the month you started
One bar per start date · the dashed line is the typical fall
An ordinary spread of falls. The lag came from slow recoveries, not deep drops.

What it actually owned

The basket is recognisably the quality growth shelf of the Indian market: Central Depository Services in every single rebuild, Tips Music, Prudent Corporate, capital light businesses earning spectacular returns and growing fast. Nothing about the list is foolish. Everything about it was popular, and popularity is a price.

The stocks it kept buying
Share of yearly rebuilds each name survived
Where the money sat · average sector weight
By company size, share of the basket
7.4%
a year for the top 30 on the single run · the index made 12.5%
2 in 3
five year starts still beat the index, at a median near 22% a year
1.2%
a year for the screen's ten favourite stocks, the cost of paying for fame
The full teardown

In the deep dive we watch the ranking sort backwards, concentration compound the damage, and the growth regime give and take. And we ask the question the formula cannot answer for itself: what turns the compounding equation from a description of great businesses into a reason to overpay for them? Short version: the formula finds quality; it cannot see the price.

Read the full teardown

The equation was never the problem

High returns reinvested into growth really is how fortunes compound; the arithmetic has built every great business story India has. What this test shows is subtler: by the time a compounder is measurable in a screen, it is usually already famous, and fame is paid for in advance. The investors who made fortunes on these businesses bought the arithmetic before it was obvious. The screen, arriving after, bought the same arithmetic at a price that had the future already inside it. Held patiently, across many starts, it still edged the market more often than not. But the lesson worth keeping is the one the ten favourite stocks taught at 1% a year: quality is a fact, and price is what decides whether the fact pays you.

So we took it to Krest, and ran it through the whole test.

KREST TESTED · RUN ON REAL HISTORY ·
Method mark
Krest Tested
We ran the Reinvestment Compounder through the test on eight years of Indian data, every start date and every holding period. The rigour is ours; the verdict is yours.

Free · no account needed

Test before you trust.

Every figure on this page came from a few clicks on Krest. See this exact analysis live and interactive, or point the same test at any strategy you have ever believed.

For education only. Not investment advice or a recommendation to buy, sell, or hold any security, strategy, or product. Past performance does not guarantee future results, and all investing carries risk, including the possible loss of capital. Make your own decisions, and consider consulting a SEBI registered investment adviser.

Best effort analysis. Prepared on a best effort basis from historical data and may contain errors, omissions, or assumptions. Shared for information and discussion only, and should be independently verified before you rely on it. Krest accepts no liability for any decision made or loss incurred based on it.

Figures reflect a reinvestment compounding screen (ranked by return on invested capital and three year sales growth, both descending, with return on invested capital above 15%, positive net profit and market cap above ₹1,000 cr), reconstructed yearly over roughly eight years of Indian data (since June 2018), measured against the Nifty 500 total return index. The compounding arithmetic draws on the quality growth literature. Because this rests on about eight years of data, a longer run of history could change the conclusions.

Krest · mykrest.com